All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0322-LX28 | Anti-CD98 (k3) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | k3 | Human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX29 | Anti-CD98 (1-40-1) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | 1-40-1 | Human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX30 | Anti-CD98 (3-69-6) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | 3-69-6 | Human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX31 | Anti-CD98 (C2IgG1) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | C2IgG1 | Human | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX32 | Anti-CD98 (8-34B) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | 8-34B | Humanized | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX33 | Anti-CD98 (18-2A) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | 18-2A | Humanized | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX190 | Anti-CD98 (k3) h(ICOS-4-1BB-CD3ζ) CAR, pCDCAR1 | Human | k3 | Human | scFv-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX198 | Anti-CD98 (18-2A 7.1) h(ICOS-4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 18-2A 7.1 | Humanized | scFv-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX199 | Anti-CD98 (1-47C) h(ICOS-4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 1-47C | Humanized | scFv-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0322-LX352 | Anti-CD98 (k3) h(CD28-CD3ζ) CAR, pSBCAR1 | Human | k3 | Human | scFv-CD28-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0422-LX424 | Anti-CD98 (1-1 15A) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | 1-1 15A | Humanized | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0422-LX425 | Anti-CD98 (R8H283) h(CD28-41BB-CD3ζ) CAR, pMMLV | Human | R8H283 | Mouse | scFv-CD28-41BB-CD3ζ | Recombinant Moloney murine leukemia virus (MMLV) retroviral vector | T cell | ||
XS-0323-LX3346 | TRAC-CD98 (k3) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | k3 | Human | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX3347 | TRAC-CD98 (1-40-1) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | 1-40-1 | Human | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX3348 | TRAC-CD98 (3-69-6) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | 3-69-6 | Human | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX3349 | TRAC-CD98 (C2IgG1) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | C2IgG1 | Human | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX3350 | TRAC-CD98 (8-34B) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | 8-34B | Humanized | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX3351 | TRAC-CD98 (18-2A) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | 18-2A | Humanized | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX3352 | TRAC-CD98 (IGN523) h(CD28-OX40-CD3ζ) replaced CAR, pcDNA Vector | Human | IGN523 | Humanized | Homology arm-EF1a-scFv-CD28-OX40-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0323-LX3505 | TRAC-CD98 (k3) h(ICOS-4-1BB-CD3ζ) replaced CAR, pcDNA Vector | Human | k3 | Human | Homology arm-EF1a-scFv-ICOS-41BB-CD3ζ-Homology arm | Nonviral | T cell | CAR-T | |
XS-0823-LX27 | Anti-hCD98 (108) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | 108 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION